Rebamipide Gastroprotective Agent

Rebamipide Gastroprotective Agent rebamipide Rebamipide is known as an antiulcer drug and acts as an oxygen radical scavenger or an antioxidant So, we examine whether rebamipide could reduce the rebamipide Abstract Rebamipide is a cytoprotector developed in Japan where it has been successfully used for the treatment of stomach diseases for 30 years Initially

rebamipide Rebamipide is a cholecystokinin type 1 receptor inhibitor for inhibiting BH-CCK-8S with IC50 of μM

rebamipide BackgroundAims: The mucoprotective drug rebamipide is used to treat gastritis and peptic ulcers We compared the efficacy of MucostaR IndicationsUses Rebamipide is indicated for use as an adjuvant in the treatment of peptic ulcer disease concomitantly with anti-secretory agents including